JP2005034154A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005034154A5 JP2005034154A5 JP2004207941A JP2004207941A JP2005034154A5 JP 2005034154 A5 JP2005034154 A5 JP 2005034154A5 JP 2004207941 A JP2004207941 A JP 2004207941A JP 2004207941 A JP2004207941 A JP 2004207941A JP 2005034154 A5 JP2005034154 A5 JP 2005034154A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- antigen
- cell
- cells
- recognizes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/622,003 US20050014230A1 (en) | 2003-07-16 | 2003-07-16 | Preparation of fully human antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005034154A JP2005034154A (ja) | 2005-02-10 |
| JP2005034154A5 true JP2005034154A5 (https=) | 2007-08-23 |
Family
ID=33477124
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004207941A Pending JP2005034154A (ja) | 2003-07-16 | 2004-07-14 | 完全ヒト抗体の調製 |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US20050014230A1 (https=) |
| EP (1) | EP1498426A1 (https=) |
| JP (1) | JP2005034154A (https=) |
| CN (1) | CN1626669A (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0917554A2 (pt) | 2008-08-01 | 2017-06-20 | Axis Inc | agente de tratamento ou agente de prevenção para oesteoartrite |
| JP2012246222A (ja) | 2010-01-29 | 2012-12-13 | Axis Inc | 変形性関節症治療剤または予防剤を製造するための使用 |
| AU2011210465A1 (en) | 2010-01-29 | 2012-08-23 | Axis Inc. | Pharmaceutical composition for treatment or prevention of osteoarthritis, and method of production therefor |
| WO2011093081A1 (ja) | 2010-01-29 | 2011-08-04 | Ａｘｉｓ株式会社 | 変形性関節症治療剤を含有する注射剤 |
| CN102212133B (zh) * | 2011-03-30 | 2013-01-16 | 中国医学科学院病原生物学研究所 | 人源HIV抗体的Fab片段及其编码基因与应用 |
| FR2998579B1 (fr) | 2012-11-27 | 2015-06-19 | Commissariat Energie Atomique | Methode pour obtenir des anticorps humains specifiques d'un antigene par immunisation in vitro |
| EP3030268B1 (en) | 2013-08-09 | 2022-07-27 | The Trustees Of The University Of Pennsylvania | Combination of ifn-gamma with anti-erbb antibody for the treatment of cancers |
| US9840555B2 (en) * | 2013-11-04 | 2017-12-12 | Li-Te Chin | Method for producing human monoclonal antibodies that binds to at least one part of HMGB1 |
| CN103755805B (zh) * | 2014-02-11 | 2015-08-12 | 中国疾病预防控制中心病毒病预防控制所 | HIV-1 Env特异性的全人单克隆抗体 |
| JP6403999B2 (ja) * | 2014-06-05 | 2018-10-10 | 株式会社細川洋行 | レトルト包装用積層体及び容器 |
| AU2017345813B2 (en) * | 2016-10-23 | 2024-06-13 | Berkeley Lights, Inc. | Methods for screening B cell lymphocytes |
| CN109157690A (zh) * | 2018-06-15 | 2019-01-08 | 翁炳焕 | 猴-人细胞融合母胎血型不合治疗杂交株的制备 |
| TW202231277A (zh) * | 2019-05-21 | 2022-08-16 | 美商基利科學股份有限公司 | 鑑別對使用gp120 v3聚醣導向之抗體的治療敏感之hiv病患的方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5023252A (en) * | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
| US5215913A (en) * | 1987-11-30 | 1993-06-01 | Roger Williams General Hospital | IgG-1 human monoclonal antibody reactive with an HIV-1 antigen and methods of use |
| US6309880B1 (en) * | 1989-04-25 | 2001-10-30 | Tanox, Inc. | Antibodies specific for CD4-binding domain of HIV-1 |
| AP237A (en) * | 1990-05-29 | 1993-04-29 | Cedars Sinai Medical Center | Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type 1 (HIV-1) gp120 and methods of use. |
| WO1994020632A1 (fr) * | 1993-03-11 | 1994-09-15 | Juridical Foundation The Chemo-Sero-Therapeutic R Esearch Insitute | Anticorps monoclonal dirige contre le vih |
| DE69435126D1 (de) * | 1993-10-19 | 2008-10-02 | Scripps Research Inst | Synthetische humane neutralisierende monoklonale antikörper gegen hiv |
| US6051256A (en) * | 1994-03-07 | 2000-04-18 | Inhale Therapeutic Systems | Dispersible macromolecule compositions and methods for their preparation and use |
| US6165463A (en) * | 1997-10-16 | 2000-12-26 | Inhale Therapeutic Systems, Inc. | Dispersible antibody compositions and methods for their preparation and use |
| US6391635B1 (en) * | 1997-11-24 | 2002-05-21 | Institute For Human Genetics And Biochemistry | Monoclonal human natural antibodies |
| WO2001000678A1 (en) * | 1999-06-30 | 2001-01-04 | The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Human monoclonal antibodies to hiv-1 envelope glycoprotein gp120 |
-
2003
- 2003-07-16 US US10/622,003 patent/US20050014230A1/en not_active Abandoned
-
2004
- 2004-07-14 JP JP2004207941A patent/JP2005034154A/ja active Pending
- 2004-07-15 CN CNA2004100684394A patent/CN1626669A/zh active Pending
- 2004-07-16 EP EP04016838A patent/EP1498426A1/en not_active Withdrawn
-
2007
- 2007-01-29 US US11/699,822 patent/US20080248531A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005034154A5 (https=) | ||
| Homann et al. | Evidence for an underlying CD4 helper and CD8 T-cell defect in B-cell-deficient mice: failure to clear persistent virus infection after adoptive immunotherapy with virus-specific memory cells from μMT/μMT mice | |
| DK1597280T4 (en) | Preparation of monoclonal antibodies by EBV transformation of B cells | |
| JP2010512749A5 (https=) | ||
| JPH0576383A (ja) | 抗体製造方法 | |
| JPS63126484A (ja) | 真核生物細胞の形質転換方法 | |
| RU2009138922A (ru) | Новые анти-r7v-антитела и их применения | |
| JP2011510654A5 (https=) | ||
| FR2746398A1 (fr) | Anticorps specifique de staphylococcus aureaus, et utilisations | |
| CN103045607A (zh) | 传染病病原体全人源化抗体的制备方法 | |
| JP2005034154A (ja) | 完全ヒト抗体の調製 | |
| JP5160412B2 (ja) | 融合パートナー細胞 | |
| JP2004502454A5 (https=) | ||
| US6013519A (en) | Monoclonal antibodies to antigens expressed by hematopoietic facilitatory cells | |
| JPS60203186A (ja) | ヒト−ヒトハイブリド−マ | |
| AU2022216617A9 (en) | Enhanced hybridoma generation | |
| EP2531525A1 (en) | In vitro process for the preparation of antibodies of the igg type | |
| JPS62181798A (ja) | モノクロ−ナル抗体 | |
| TW200406421A (en) | Monoclonal antibody specific for an epitope of inactivated feline immunodeficiency-encoded glycoprotein | |
| Lakshmi et al. | Automated GMP-compatible production of universal CAR Tregs for organ-targeted tolerance induction | |
| Morris et al. | Broadly neutralizing antibodies | |
| James | Human monoclonal antibody technology | |
| Testorelli et al. | Monoclonal antibodies to the L1210 murine leukemia cell line and to a drug-altered subline | |
| RU2012594C1 (ru) | Штамм гибридных культивируемых клеток животных mus musculus l - продуцент моноклональных антител к 146s-компоненту вируса ящура азия-1 | |
| JPH0551277B2 (https=) |